Happy Clinical Trials Day! 🔬 At Phortas, we celebrate the incredible advancements and unwavering dedication that clinical trials bring to the world of healthcare. Today, we honor the researchers, patients, participants, and professionals who work tirelessly to transform innovative ideas into life-saving treatments. Clinical trials are the cornerstone of medical progress, ensuring new therapies are safe and effective. They embody the spirit of collaboration, scientific rigor, and hope for a healthier future. As a leading consultancy in Regulatory Affairs and Drug Development, Phortas is proud to support these vital efforts, helping to guide clinical research and bring new therapies to those in need. Thank you to everyone involved in this noble pursuit, especially the patients who make these advancements possible. Let's continue to push the boundaries of science and improve lives globally. #ClinicalTrialsDay #ClinicalResearch #DrugDevelopment #Phortas #RegulatoryAffairs #MedicalInnovation #HealthcareAdvancement #regulatoryaffairs #research #biotech #pharmaceuticalindustry
Phortas’ Post
More Relevant Posts
-
Speaker/Panelist Acquisition for our 22nd BioPharma Clinical Trials Nexus Conference on 13th-14th March, 2025 in Basel, Switzerland.
Join this esteemed event to elevate your Clinical Trials game. #CLINICALTRIALS #BIOPHARMANEXUS
Unlock the future of clinical excellence at the 21st BioPharma Clinical Trials Nexus 🌟 Join us on October 22nd & 23rd, 2024 in Princeton, New Jersey, for two days of groundbreaking insights, networking, and innovation in the biopharma industry. Don't miss this opportunity to connect with leaders and pioneers driving the next wave of clinical advancements. 📈✨ 📅 Date: October 22-23, 2024 📍 Location: Princeton, NJ 🔗 Register now: https://lnkd.in/dSz-gc7c #ClinicalTrials #BioPharma #ClinicalExcellence #Innovation #Healthcare #PharmaLeaders #Research #Biotech #Networking #MedicalResearch
-
-
📣 Check out the third issue of 2023 of the “What’s New In Regulatory Science newsletter” from the Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER). This issue contains updates on CDER research & other regulatory science efforts that help advance medical product development. https://lnkd.in/esDdimD7
-
Wrapping up 2023 and heading into 2024! As we begin to close the chapter on 2023 and start looking towards 2024 many companies within life sciences and teams within biotech, biopharma, therapeutic, and med device companies are of course looking to increase ROI. What if I told you there is a platform to increase ROI by productivity efficiency? That platform is called Monocl ExpertInsight! Monocl enables teams to increase productivity efficiency by seamlessly identifying and streamlining key data for Medical Affairs, Scientific, and Clinical teams. Monocl gives you the ability to access over 15 million expert profiles such as Key Opinion Leaders, key and principal investigators, HCPs, and more. These expert profiles cover the entire globe and all therapeutic areas, all indications, all diseases, with access to experts clinical trials, clinical activity, meeting presentations, grants, publications, collaborators, industry-sponsored trials, and more! To learn more about Monocl ExpertInsight feel free to send me a message or leave a comment on this post! #MedicalAffairs #KOL #KeyOpinionLeaders #Clinical #ClinicalTrials #ClinicalDevelopment #Monocl #Lifesciences #biotech #pharma #therapeutics
-
🌟 New Poster Published! 🌟 Check out our latest research on Peeref: "The Burden of Adverse Drug Reactions: Challenges and Opportunities." 🔍 Our study highlights the significant costs of adverse drug reactions (ADRs) and the need for innovative solutions such as real-world evidence, OMICS, and AI to predict and prevent ADRs. Reducing the impact of ADRs requires collaboration among MAHs, regulators, academia, patients, and health systems. Investment in research and technology is key. ⬇ Click the link below to explore our full poster and join the conversation! 💬 https://lnkd.in/eEbv2TWQ Together, let's drive forward advancements in future healthcare! 🏥✨ #Pharmacovigilance #DrugSafety #PublicHealth #Research #Innovation #Collaboration #AdverseDrugReaction Regulatory Affairs and Drug Development - M.Sc. Study Program, Albert-Ludwigs-Universität Freiburg im Breisgau, Andreas Bechthold, Stefan Guenther, Dr. Anja Langeneckert, Dr. Marion Mueller
-
Decentralized clinical trials(DCTs) represent advancements in clinical research and have the potential to improve access to trials, allowing for improvements in patient recruitment, retention, and diversity, but adoption is key. Choosing the right technology partner and having a well-thought-out and executed strategy will allow life science companies to capitalize on the potential of DCTs, ultimately bringing new drugs, vaccines, and devices to market faster. Find out more about Techorizon's offerings and how we can support you with your Decentralized Clinical project! https://lnkd.in/eTcaSQq #LifeSciences #techorizon #edc #ecrf #ecrf #technology #edc #LifeSciences #clinicaltrials #clinicalresearch #healthcare #healthtech #healthtechnology #decentralizedtrials
-
-
🔊 Call for abstracts! 🔊 Is your research focused on exploring novel approaches to advance #DrugRepurposing globally? Then you could be one of the speakers at #RExPO24 💊 💡 Whether you're interested in giving a main talk or presenting a poster, this is your chance to present your work in front of international peers from across the entire #PharmaInnovation landscape — from drug repurposing, formulation and discovery, all the way to patient engagement, patenting, trials and regulatory affairs. Find all the information you need on our website, including a how-to guide for submitting your abstract via ScienceOpen ➡ https://lnkd.in/e2PBnicG ⏰ Deadline closes on the 3rd of May, and we strongly encourage early submissions! Find out more about RExPO24, the 3rd international conference on Systems Medicine and Drug Repurposing 👉 https://repo4.eu/rexpo24/ #CallForAbstracts #DrugResearch #MedicalResearch #MedTech #HealthTechInnovation #MedicalConference #FutureOfMedicine
-
Decentralized clinical trials (DCTs) represent advancements in clinical research and have the potential to improve access to trials, allowing for improvements in patient recruitment, retention, and diversity, but adoption is key. Choosing the right technology partner and having a well-thought-out and executed strategy will allow life science companies to capitalize on the potential of DCTs, ultimately bringing new drugs, vaccines, and devices to market faster. Find out more about Techorizon's offerings and how we can support you! https://lnkd.in/eTcaSQq #LifeSciences #techorizon #edc #ecrf #ecrf #technology #edc #LifeSciences #clinicaltrials #clinicalresearch #healthcare #healthtech #healthtechnology #decentralizedtrials #DCTs
-
-
The FDA Public Workshop "Streamlining Drug Development and Improving Public Health through Quantitative Medicine" held on April 25, 2024 is now available to view on YouTube! This workshop was hosted by the newly established FDA Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence (QM CoE). It provided an overview of the scope, goals, and current state of this new CoE, while gaining feedback from the public on needs and opportunities in education, outreach, and policy. Visit FDA's YouTube Channel to view this public event: https://lnkd.in/drCXdG7T #FDA #publichealth #quantitativemedicine #clinicalpharmacology #modeling #modelingandsimulation #drugdevelopment #translationalsciences #drugs #generics #engagement #stakeholders #regulatoryscience #policy
-
-
Associate Director for Guidance and Scientific Policy at Immediate Office, Office of Clinical Pharmacology
Missed the live FDA Workshop on "Streamlining Drug Development and Improving Public Health through Quantitative Medicine"? Don’t worry! You can now watch the full session on YouTube. 👉 Check it out here and join the conversation: https://lnkd.in/drCXdG7T #FDA #publichealth #quantitativemedicine #clinicalpharmacology #modeling #modelingandsimulation #drugdevelopment #translationalsciences #drugs #generics #engagement #stakeholders #regulatoryscience #policy #MIDD
The FDA Public Workshop "Streamlining Drug Development and Improving Public Health through Quantitative Medicine" held on April 25, 2024 is now available to view on YouTube! This workshop was hosted by the newly established FDA Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence (QM CoE). It provided an overview of the scope, goals, and current state of this new CoE, while gaining feedback from the public on needs and opportunities in education, outreach, and policy. Visit FDA's YouTube Channel to view this public event: https://lnkd.in/drCXdG7T #FDA #publichealth #quantitativemedicine #clinicalpharmacology #modeling #modelingandsimulation #drugdevelopment #translationalsciences #drugs #generics #engagement #stakeholders #regulatoryscience #policy
-
-
The FDA CDER Quantitative Medicine Center of Excellence workshop recording is now available. #FDA #publichealth #quantitativemedicine #clinicalpharmacology #modeling #modelingandsimulation #drugdevelopment #translationalsciences #drugs #generics #engagement #stakeholders #regulatoryscience #policy
The FDA Public Workshop "Streamlining Drug Development and Improving Public Health through Quantitative Medicine" held on April 25, 2024 is now available to view on YouTube! This workshop was hosted by the newly established FDA Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence (QM CoE). It provided an overview of the scope, goals, and current state of this new CoE, while gaining feedback from the public on needs and opportunities in education, outreach, and policy. Visit FDA's YouTube Channel to view this public event: https://lnkd.in/drCXdG7T #FDA #publichealth #quantitativemedicine #clinicalpharmacology #modeling #modelingandsimulation #drugdevelopment #translationalsciences #drugs #generics #engagement #stakeholders #regulatoryscience #policy
-
